| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | — | +103.7% |
| Cost of Revenue | $2.6M | — | +154.8% |
| Gross Profit | $18K | — | -93.1% |
| R&D Expense | $356K | — | +61.1% |
| SG&A Expense | $703K | — | +1.0% |
| Operating Income | -$1.0M | — | -53.9% |
| Pre-tax Income | -$742K | — | -35.6% |
| Net Income | -$742K | — | -35.6% |
| EPS (Basic) | -$0.09 | — | -12.5% |
| EPS (Diluted) | -$0.09 | — | -12.5% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.9M | +11.4% | +131.5% |
| Accounts Receivable | $1.9M | -48.0% | +615.3% |
| Inventory | $3.9M | -17.9% | +5.4% |
| Current Assets | $10.2M | -9.3% | +86.5% |
| Total Assets | $14.2M | -8.7% | +36.8% |
| Current Liabilities | $10.9M | -4.1% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $361K | — | +328.5% |
| Capital Expenditures | $30K | — | -74.6% |
| Investing Cash Flow | -$1K | — | +99.2% |
| Financing Cash Flow | -$116K | — | +52.5% |
| Free Cash Flow | $331K | — | +219.9% |
| +53.5% |
| Long-term Debt | $308K | -82.0% | -58.6% |
| Total Liabilities | $12.2M | -5.1% | +37.9% |
| Stockholders' Equity | $2.1M | -25.6% | +30.9% |